The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gabapentin plus tramadol versus tramadol alone for chemoradiotherapy-induced oral mucositis pain in head and neck cancer: Results of a randomized phase III trial.
 
Minit Shah
No Relationships to Disclose
 
Nandini Menon
No Relationships to Disclose
 
Vanita Noronha
Research Funding - AstraZeneca (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Nanobiotix (Inst); Novartis (Inst); Roche India (Inst)
Travel, Accommodations, Expenses - American Society of Clinical Oncology
 
Vijay Patil
Research Funding - AstraZeneca (Inst); Eisai Germany (Inst); Intas (Inst); Johnson & Johnson/Janssen (Inst); NATCO Pharma (Inst); Novartis (Inst)
 
Laxman Sahu
No Relationships to Disclose
 
Ajay Upadhayay
No Relationships to Disclose
 
Ashok Singhal
No Relationships to Disclose
 
Anjali Shah
No Relationships to Disclose
 
Aravind Padmanabhan
No Relationships to Disclose
 
Ayman Shaikh
No Relationships to Disclose
 
Harshada Arolkar
No Relationships to Disclose
 
Sandhyarani Nishank
No Relationships to Disclose
 
Gargi Patlekar
No Relationships to Disclose
 
Yashashree Parida
No Relationships to Disclose
 
Kavita Nawale
No Relationships to Disclose
 
Harshal Mungekar
No Relationships to Disclose
 
Ashwini Budrukkar
No Relationships to Disclose
 
Naveen Mummudi
No Relationships to Disclose
 
Sarbani Ghosh-Laskar
No Relationships to Disclose
 
Kumar Prabhash
Research Funding - Alkem Laboratories (Inst); Aurigene Oncology Limited (Inst); BDR Pharmaceutics (Inst); Biocon (Inst); Biorasi Clinical Sci Pvt (Inst); Dr. Reddy's Laboratories (Inst); Fortrea (Inst); Fresenius Kabi (Inst); Hexal Pharmaceuticals (Inst); Johnson and Johnson (Inst); Jubilant Therapeutics (Inst); MSD (Inst); NATCO Pharma (Inst); Novartis (Inst); Roche (Inst); Samsung Bioepis (Inst)